Boston Scientific, J&J Unit End Aneurysm Patent Spat

Law360, New York (March 12, 2009, 12:00 AM EDT) -- Just two days before going to trial, Johnson & Johnson unit Cordis Neurovascular Inc. and Boston Scientific Corp. settled their long-running dispute over three patents related to a device for treating aneurysms, less than a year after a judge ruled that Cordis had infringed two of the patents licensed to Boston Scientific.

Judge James Ware of the U.S. District Court for the Northern District of California on Wednesday signed off on a stipulated dismissal of the suit with prejudice.

A day before jury selection was scheduled...
To view the full article, register now.